SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-002322
Filing Date
2010-01-21
Accepted
2010-01-21 06:13:04
Documents
7
Period of Report
2010-01-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-1956_58k.htm 8-K 37155
2 EX-1.1 a10-1956_5ex1d1.htm EX-1.1 220958
3 EX-5.1 a10-1956_5ex5d1.htm EX-5.1 11647
4 EX-99.1 a10-1956_5ex99d1.htm EX-99.1 11847
5 GRAPHIC g19565moi001.jpg GRAPHIC 3090
6 GRAPHIC g19565kgi001.jpg GRAPHIC 2798
7 GRAPHIC g19565kgi002.jpg GRAPHIC 2801
  Complete submission text file 0001104659-10-002322.txt   295659
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 10537597
SIC: 2835 In Vitro & In Vivo Diagnostic Substances